We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cardiology
 61-65 of 65 Articles
Original Article |  FREE
Anne T. Harvey, PhD; Richard L. Rudolph, MD; Sheldon H. Preskorn, MD
Arch Gen Psychiatry. 2000;57(5):503-509. doi:10.1001/archpsyc.57.5.503.

Original Article |  FREE
Andrew L. Stoll, MD; W. Emanuel Severus, MD, PhD; Marlene P. Freeman, MD; et al.
Arch Gen Psychiatry. 1999;56(5):407-412. doi:10.1001/archpsyc.56.5.407.

Original Article |  FREE
Stephen R. Dager, MD; Seth D. Friedman, PhD; Aaron Heide, MD; et al.
Arch Gen Psychiatry. 1999;56(1):70-77. doi:10.1001/archpsyc.56.1.70.

Original Article |  FREE
Adolf Pfefferbaum, MD; Edith V. Sullivan, PhD; Margaret J. Rosenbloom, MA; et al.
Arch Gen Psychiatry. 1998;55(10):905-912. doi:10.1001/archpsyc.55.10.905.

News and Views | 
Dominique L. Musselman, MD; Dwight L. Evans, MD; Charles B. Nemeroff, MD, PhD
Arch Gen Psychiatry. 1998;55(7):580-592. doi:10.1001/archpsyc.55.7.580.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
Original Investigation  | 
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction The SOCRATES-REDUCED Randomized Trial
Mihai Gheorghiade, MD; Stephen J. Greene, MD; Javed Butler, MD, MPH, MBA; et al.
News From the Food and Drug Administration  | 
Anticoagulant Can Be Reversed
Rebecca Voelker, MSJ
From The Medical Letter on Drugs and Therapeutics  | 
Evolocumab (Repatha)—A Second PCSK9 Inhibitor to Lower LDL-Cholesterol

Original Investigation  | 
CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea A Systematic Review and Meta-analysis
Daniel J. Bratton, PhD; Thomas Gaisl, MD; Annette M. Wons, MD; et al.